678 related articles for article (PubMed ID: 23687439)
1. Novel epithelial cell adhesion molecule antibody conjugated polyethyleneimine-capped gold nanoparticles for enhanced and targeted small interfering RNA delivery to retinoblastoma cells.
Mitra M; Kandalam M; Rangasamy J; Shankar B; Maheswari UK; Swaminathan S; Krishnakumar S
Mol Vis; 2013; 19():1029-38. PubMed ID: 23687439
[TBL] [Abstract][Full Text] [Related]
2. Enhanced in vitro antiproliferative effects of EpCAM antibody-functionalized paclitaxel-loaded PLGA nanoparticles in retinoblastoma cells.
Mitra M; Misra R; Harilal A; Sahoo SK; Krishnakumar S
Mol Vis; 2011; 17():2724-37. PubMed ID: 22065926
[TBL] [Abstract][Full Text] [Related]
3. Gold nanoparticles capped with polyethyleneimine for enhanced siRNA delivery.
Song WJ; Du JZ; Sun TM; Zhang PZ; Wang J
Small; 2010 Jan; 6(2):239-46. PubMed ID: 19924738
[TBL] [Abstract][Full Text] [Related]
4. EpCAM aptamer mediated cancer cell specific delivery of EpCAM siRNA using polymeric nanocomplex.
Subramanian N; Kanwar JR; Athalya PK; Janakiraman N; Khetan V; Kanwar RK; Eluchuri S; Krishnakumar S
J Biomed Sci; 2015 Jan; 22():4. PubMed ID: 25576037
[TBL] [Abstract][Full Text] [Related]
5. Efficient targeted pDNA/siRNA delivery with folate-low-molecular-weight polyethyleneimine-modified pullulan as non-viral carrier.
Wang J; Dou B; Bao Y
Mater Sci Eng C Mater Biol Appl; 2014 Jan; 34():98-109. PubMed ID: 24268238
[TBL] [Abstract][Full Text] [Related]
6. Bioconjugated Gold Nanoparticles Enhance siRNA Delivery in Prostate Cancer Cells.
Rahme K; Guo J; Holmes JD
Methods Mol Biol; 2019; 1974():291-301. PubMed ID: 31099011
[TBL] [Abstract][Full Text] [Related]
7. Oncogenic microRNA 17-92 cluster is regulated by epithelial cell adhesion molecule and could be a potential therapeutic target in retinoblastoma.
Kandalam MM; Beta M; Maheswari UK; Swaminathan S; Krishnakumar S
Mol Vis; 2012; 18():2279-87. PubMed ID: 22969266
[TBL] [Abstract][Full Text] [Related]
8. Delivering siRNA to control osteogenic differentiation and real-time detection of cell differentiation in human mesenchymal stem cells using multifunctional gold nanoparticles.
Wu Q; Wang K; Wang X; Liang G; Li J
J Mater Chem B; 2020 Apr; 8(15):3016-3027. PubMed ID: 32207489
[TBL] [Abstract][Full Text] [Related]
9. Controlled synthesis of PEI-coated gold nanoparticles using reductive catechol chemistry for siRNA delivery.
Lee Y; Lee SH; Kim JS; Maruyama A; Chen X; Park TG
J Control Release; 2011 Oct; 155(1):3-10. PubMed ID: 20869409
[TBL] [Abstract][Full Text] [Related]
10. Efficacious cellular codelivery of doxorubicin and EGFP siRNA mediated by the composition of PLGA and PEI protected gold nanoparticles.
Kumar K; Vulugundam G; Jaiswal PK; Shyamlal BRK; Chaudhary S
Bioorg Med Chem Lett; 2017 Sep; 27(18):4288-4293. PubMed ID: 28838699
[TBL] [Abstract][Full Text] [Related]
11. Target-specific delivery of doxorubicin to retinoblastoma using epithelial cell adhesion molecule aptamer.
Subramanian N; Raghunathan V; Kanwar JR; Kanwar RK; Elchuri SV; Khetan V; Krishnakumar S
Mol Vis; 2012; 18():2783-95. PubMed ID: 23213278
[TBL] [Abstract][Full Text] [Related]
12. [Small interfering RNA delivery mediated by mPEG-PCL-g-PEI polymer nanoparticles].
Huang W; Lü M; Gao ZG; Jin MJ; Yang CQ
Yao Xue Xue Bao; 2011 Mar; 46(3):344-9. PubMed ID: 21626792
[TBL] [Abstract][Full Text] [Related]
13. Enhanced gene delivery and siRNA silencing by gold nanoparticles coated with charge-reversal polyelectrolyte.
Guo S; Huang Y; Jiang Q; Sun Y; Deng L; Liang Z; Du Q; Xing J; Zhao Y; Wang PC; Dong A; Liang XJ
ACS Nano; 2010 Sep; 4(9):5505-11. PubMed ID: 20707386
[TBL] [Abstract][Full Text] [Related]
14. Anisamide-targeted PEGylated gold nanoparticles designed to target prostate cancer mediate: Enhanced systemic exposure of siRNA, tumour growth suppression and a synergistic therapeutic response in combination with paclitaxel in mice.
Luan X; Rahme K; Cong Z; Wang L; Zou Y; He Y; Yang H; Holmes JD; O'Driscoll CM; Guo J
Eur J Pharm Biopharm; 2019 Apr; 137():56-67. PubMed ID: 30779980
[TBL] [Abstract][Full Text] [Related]
15. Modified gold-based siRNA nanotherapeutics for targeted therapy of triple-negative breast cancer.
Shahbazi R; Asik E; Kahraman N; Turk M; Ozpolat B; Ulubayram K
Nanomedicine (Lond); 2017 Aug; 12(16):1961-1973. PubMed ID: 28745127
[TBL] [Abstract][Full Text] [Related]
16. Bioconjugated gold nanoparticles enhance cellular uptake: A proof of concept study for siRNA delivery in prostate cancer cells.
Guo J; O'Driscoll CM; Holmes JD; Rahme K
Int J Pharm; 2016 Jul; 509(1-2):16-27. PubMed ID: 27188645
[TBL] [Abstract][Full Text] [Related]
17. Epithelial cell adhesion molecule targeted nutlin-3a loaded immunonanoparticles for cancer therapy.
Das M; Sahoo SK
Acta Biomater; 2011 Jan; 7(1):355-69. PubMed ID: 20727991
[TBL] [Abstract][Full Text] [Related]
18. Low-weight polyethylenimine cross-linked 2-hydroxypopyl-β-cyclodextrin and folic acid as an efficient and nontoxic siRNA carrier for gene silencing and tumor inhibition by VEGF siRNA.
Li JM; Wang YY; Zhang W; Su H; Ji LN; Mao ZW
Int J Nanomedicine; 2013; 8():2101-17. PubMed ID: 23766646
[TBL] [Abstract][Full Text] [Related]
19. Multifunctional PEI-entrapped gold nanoparticles enable efficient delivery of therapeutic siRNA into glioblastoma cells.
Kong L; Qiu J; Sun W; Yang J; Shen M; Wang L; Shi X
Biomater Sci; 2017 Jan; 5(2):258-266. PubMed ID: 27921110
[TBL] [Abstract][Full Text] [Related]
20. Sialic Acid-Targeted Nanovectors with Phenylboronic Acid-Grafted Polyethylenimine Robustly Enhance siRNA-Based Cancer Therapy.
Ji M; Li P; Sheng N; Liu L; Pan H; Wang C; Cai L; Ma Y
ACS Appl Mater Interfaces; 2016 Apr; 8(15):9565-76. PubMed ID: 27007621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
